4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-000867
Chief Commercial Officer sold 74 shares at $33.89 ($2,508)
- Chief Commercial Officer acquired 75,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Oliver Tracie Chief Commercial Officer | 2024-01-04 | Grant or award 10b5-1 | +75,000 | 136,575 | D: show line 1 in the form | ||
| Oliver Tracie Chief Commercial Officer | 2024-01-05 | Sale 10b5-1 | −74 | $33.89 | $2,508 | 136,501 | D: show line 2 in the form |
| Open-market sales · 74 sh · avg $33.89 · $2,508 | |||||||
Loading xslF345X05/wk-form4_1704752243.xml…